Patents by Inventor Gilles Andre Lajoie

Gilles Andre Lajoie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140065119
    Abstract: Compositions and methods for treating wounds are provided. The compositions include cyclic analogues of histatin (5).
    Type: Application
    Filed: November 10, 2011
    Publication date: March 6, 2014
    Applicant: THE UNIVERSITY OF WESTERN ONTARIO
    Inventors: Gilles Andre Lajoie, Greg John Adams Vilk, Ian Welch
  • Publication number: 20100173833
    Abstract: Provided are novel compositions and therapeutic methods for treating bacterial and fungal disease with cyclic analogues of histatin. The cyclic analogues of histatin are advantageously more potent but less toxic than currently used anti-microbial agents. In addition, compositions comprising the cyclic analogue with other anti-microbial agents such as azole compounds are disclosed.
    Type: Application
    Filed: May 5, 2008
    Publication date: July 8, 2010
    Inventors: Gilles Andre Lajoie, Greg John Adams Vilk, Dyanne Patricia Brewer
  • Publication number: 20100113286
    Abstract: Biomarkers associated with preeclampsia were identified. Nine proteins were identified as being differentially regulated between the control and the under 28-weeks preeclamptic samples. Similarly three proteins were identified as being differentially regulated between the control and the over 28-weeks preeclamptic samples. These 12 proteins can be used as potential biomarkers in the diagnosing and prognosing of preeclampsia.
    Type: Application
    Filed: May 5, 2008
    Publication date: May 6, 2010
    Inventors: Gilles Andre Lajoie, Victor Khin Maung Han, Aaron Timothy Booy
  • Patent number: 6555650
    Abstract: Cyclic analogues of histatin H-5, having from about 7-20 amino acid units exhibiting substantial homology to histatin H-5, and having a cyclic portion of from 5-16 of the amino acid units, have been found to exhibit enhanced bio-activity against a variety of different microorganisms. The cyclic structure is imparted by replacement of naturally occurring amino acids in histatin-5 sequences by, for example, by cysteine units, so as to cause cyclization through formation of disulfide bridges.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: April 29, 2003
    Inventors: Gilles Andre Lajoie, Dyanne Brewer